The global proteinase activated receptor market is anticipated to grow at a significant CAGR during the forecast period. Proteinase-activated receptors (PARs) are a subfamily of G protein-coupled receptors (GPCRs). These receptors have four members which include PAR1, PAR2, PAR3 and PAR4. These receptors play critical applications in hemostasis, thrombosis, embryonic development; wound healing, inflammation and cancer progression. The major factor driving the growth of the global proteinase activated receptor market is the rising prevalence of cancer across the globe.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/proteinase-activated-receptor-market
According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Additionally, the most common cancers include breast cancer, lung and bronchus cancer, and leukemia, among others. In men, prostate, lung, and colorectal cancers will account for an estimated 43% of all cancers diagnosed while for women, the three most common cancers include breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in women in 2020.
Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Hence, the rising prevalence of cancer is increasing the demand for proteinase activated receptors to treat cancer progression which in turn is driving the growth of the market. Some major players in the market include Merck & Co., Inc., and Heptares Therapeutics Ltd., among others.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Merck & Co., Inc., and Heptares Therapeutics Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Proteinase Activated Receptor Market Report by Segment
By Type
- PAR1
- PAR2
- PAR3
- PAR4
By Application
- Hemostasis
- Hrombosis
- Embryonic Development
- Wound Healing
- Inflammation
- Cancer
A full report of Proteinase Activated Receptor Market is available at: https://www.omrglobal.com/industry-reports/proteinase-activated-receptor-market
Proteinase Activated Receptor Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Merck & Co., Inc.
- Heptares Therapeutics Ltd.
